Retrospective study of venous thromboembolic and intracerebral hemorrhagic events in glioblastoma patients

Anticancer Research

Volumn 29, Issue 10, 2009, Pages 4309-4313

  Pan, Edward ^a   Tsai, Jerry S ^b   Mitchell, Susan B ^c  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b Clintuition   (United States)

^c FLORIDA HOSPITAL   (United States)

Author keywords

Anticoagulant; Cerebral hemorrhage; Glioblastoma; Pulmonary embolism; Venous glioblastoma; Venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; ENOXAPARIN; TAMOXIFEN; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; INCIDENCE; INFERIOR CAVA VEIN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROBABILITY; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CEREBRAL HEMORRHAGE; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VENOUS THROMBOEMBOLISM;

EID: 71949130548     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Brandes AA, Scelzi E, Salmistraro G et al: Incidence of risk of thromboembolism during treatment high-grade gliomas: a prospective study. Eur J Cancer 33: 1592-1596, 1997. (Pubitemid 28123480)
2. Dhami MS, Bona RD, Calogero JA et al: Venous thromboembolism and high-grade gliomas. Thromb Haemost 70: 393-396, 1993.
3. Marras LC, Geerts WH and Perry JR: The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review. Cancer 59: 640-646, 2000.
4. Quevedo JF, Buckner JC, Schmidt JL et al: Thromboembolism in patients with high-grade glioma. Mayo Clin Proc 69: 329-332, 1994.
5. Wen PY and Marks PW: Medical management of patients with brain tumors. Curr Opin Oncol 14: 299-307, 2002. (Pubitemid 34492862)
6. Ruff RL and Posner JB: Incidence and treatment of peripheral venous thrombosis in patients with glioma. Ann Neurol 13: 334-336, 1983.
7. Lyman GH, Khorana AA, Falanga A et al: American Society of Clinical Oncology Guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 25: 5490-5505, 2007. (Pubitemid 350232226)
8. Levin JM, Schiff D, Loeffler JS et al: Complications of therapy for venous thromboembolic disease in patients with brain tumors. Neurology 43: 1111-1114, 1993. (Pubitemid 23177708)
9. Agnelli G, Piovella F, Buoncristiani P et al: Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med 339: 80-85, 1998. (Pubitemid 28304882)
10. Choucair AK, Silver P and Levin VA: Risk of intracranial hemorrhage in glioma patients receiving anticoagulant therapy for venous thromboembolism. J Neurosurg 66: 357-358, 1987. (Pubitemid 17031461)
11. Hamada K, Kuratsu J, Saitoh Y et al: Expression of tissue factor correlates with grade of malignancy in human glioma. Cancer 77: 1877-1883, 1996.
12. Bastida E, Ordinas A, Escolar G et al: Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis. Blood 64: 177-184, 1984. (Pubitemid 14083873)
13. Celi A, Pellegrini G, Lorenzet R et al: P-Selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci USA 91: 8767-8771, 1994.
14. Ay C, Simanek R, Vormittag R et al: High plasma levels of soluble P-selectin are predictive of venous thromboemolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Blood 112: 2703-2708, 2008.